CYP1A2, CYP2D6, GSTM1, GSTP1 and GSTT1 gene polymorphisms in patients with bladder cancer in a Turkish population

International Urology and Nephrology

Volumn 41, Issue 2, 2009, Pages 259-266

  Altayli, Ertan ^a   Gunes, Sezgin ^a   Yilmaz, Ali Faik ^a   Goktas, Serdar ^b   Bek, Yuksel ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Bladder cancer; CYP1A2; CYP2D6; GSTM1; GSTP1; GSTT1 polymorphism

Indexed keywords

ALBUMIN; CYTOCHROME P450 1A2; CYTOCHROME P450 2D6; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1;

ADULT; ARTICLE; BLADDER CANCER; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; TURKEY (REPUBLIC);

AGE FACTORS; AGED; ALCOHOL DRINKING; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP2D6; FEMALE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEX FACTORS; SMOKING; TURKEY; URINARY BLADDER NEOPLASMS;

EID: 67349146478     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-008-9444-6     Document Type: Article

References (31)

1. Sanyal S, Festa F, Sakano S, Zhang Z, Steineck G, Norming U et al (2004) Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25(5):729-734. doi: 10.1093/carcin/bgh058
2. The Health Ministry of Republic of Turkey (2000) The final report of national disease responsibility and the project of cost-effectiveness. Ankara
3. Franekova M, Halasova E, Bukovska E, Luptak J, Dobrota D (2008) Gene polymorphisms in bladder cancer. Urol Oncol 26(1):1-8. doi: 10.1016/ j.urolonc.2006.10.011
4. Rodriguez-Antona C, Ingelman-Sundberg M (2006) Cytochrome P 450 pharmacogenetics and cancer. Oncogene 25(11):1679-1691. doi: 10.1038/ sj.onc.1209377
5. Gago-Dominguez M, Bell DA, Watson MA, Yuan JM, Castelao JE, Hein DW et al (2003) Permanent hair dyes and bladder cancer: Risk modification by cytochrome p4501A2 and N-acetyltransferases 1 and 2. Carcinogenesis 24(3):483-489. doi: 10.1093/carcin/24.3.483
6. Strange RC, Spiteri MA, Ramachandran S, Fryer AA (2001) Glutathione-S-transferase family of enzymes. Mutat Res 482(1-2):21-26. doi: 10.1016/S0027-5107(01)00206-8
7. Fishbain DA, Fishbain D, Lewis J, Cutler RB, Cole B, Rosomoff HL et al (2004) Genetic testing for enzymes of drug metabolism: Does it have clinical utility for pain medicine at the present time? Pain Med 5(1):81-93. doi: 10.1111/j.1526-4637.2004.04007.x
8. Srivastava DSL, Mishra DK, Mandhani A, Mittal B, Kumar A, Mittal RD (2005) Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer. Eur Urol 48(2):339-344. doi: 10.1016/j.eururo.2005.02.007
9. Hu X, Ji X, Srivastava SK, Xia H, Awasthi S, Nanduri B et al (1997) Mechanism of differential catalytic efficiency of the two polymorphic forms of the human glutathione S -transferase P1-1 in the glutathione conjugation of carcinogenic diol epoxide of chrysene. Arch Biochem Biophys 345(1):32-38. doi: 10.1006/abbi.1997.0269
10. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215. doi: 10.1093/nar/16.3.1215
11. Basile VS, Ozdemir V, Masellis M, Walker ML, Meltzer HY, Lieberman JA et al (2000) A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: Association with tardive dyskinesia in schizophrenia. Mol Psychiatry 5(4):410-417. doi: 10.1038/sj.mp. 4000736
12. Sobti RC, Al-Badran AI, Sharma S, Sharma SK, Krishan A, Mohan H (2005) Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 bladder cancer risk in North India. Cancer Genet Cytogenet 156(1):68-73. doi: 10.1016/ j.cancergencyto.2004.04.001
13. Arand M, Mühlbauer R, Hengstler J, Jäger E, Fuchs J, Winkler L et al (1996) A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal Biochem 236(1):184-186. doi: 10.1006/abio.1996.0153
14. Fanlo A, Sinuès B, Mayayo E, Bernal L, Soriano A, Martínez-Jarreta B et al (2004) Urinary mutagenicity, CYP1A2 and NAT2 activity in textile industry workers. J Occup Health 46(6):440-447. doi: 10.1539/joh.46.440
15. Jong Jeong H, Jin Kim H, Young Seo I, Ju Kim H, Oh GJ, Cheon Chae S et al (2003) Association between glutathione S-transferase M1 and T1 polymorphisms and increased risk for bladder cancer in Korean smokers. Cancer Lett 202(2):193-199. doi: 10.1016/j.canlet.2003.09.007
16. Moore LE, Wiencke JK, Bates MN, Zheng S, Rey OA, Smith AH (2004) Investigation of genetic polymorphisms and smoking in a bladder cancer case control study in Argentina. Cancer Lett 211(2):199-207. doi: 10.1016/j.canlet.2004.04.011
17. Landi MT, Sinha R, Lang NP, Kadlubar FF (1999) Human cytochrome P4501A2. IARC Sci Publ 148:173-195
18. Han XM, Ou-Yang DS, Lu PX, Jiang CH, Shu Y, Chen XP et al (2001) Plasma caffeine metabolite ratio (17X/137X) in vivo associated with G-2964A and C734A polymorphism of human CYP1A2. Pharmacogenetics 11(5):429-435. doi: 10.1097/00008571-200107000-00006
19. Törüner GA, Akyerli C, Uçar A, Aki T, Atsu N, Ozen H et al (2001) Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population. Arch Toxicol 75(8):459-464. doi: 10.1007/s002040100268
20. Cengiz M, Ozaydin A, Ozkilic AC, Dedekarginoglu G (2007) The investigation of GSTT1, GSTM1 and SOD polymorphism in bladder cancer patients. Int Urol Nephrol 39(4):1043-1048. doi: 10.1007/ s11255-007-9179-9
21. Aktas D, Ozen H, Atsu N, Tekin A, Sozen S, Tuncbilek E (2001) Glutathione S-transferase M1 gene polymorphism in bladder cancer patients. a marker for invasive bladder cancer? Cancer Genet Cytogenet 125(1):1-4. doi: 10.1016/S0165-4608(00)00307-1
22. Kim EJ, Jeong P, Quan C, Kim J, Bae SC, Yoon SJ et al (2005) Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: Useful determinants for clinical outcome of bladder cancer. Urology 65(1):70-75. doi: 10.1016/ j.urology.2004.08.005
23. Shao J, Gu M, Zhang Z, Xu Z, Hu Q, Qian L (2008) Genetic variants of the cytochrome P450 and glutathione S-transferase associated with risk of bladder cancer in a south-eastern Chinese population. Int J Urol 15(3):216-221. doi: 10.1111/j.1442-2042.2007.01915.x
24. Salagovic J, Kalina I, Habalova V, Hrivnak M, Valansky L, Biros E (1999) The role of human glutathione S-transferases M1 and T1 in individual susceptibility to bladder cancer. Physiol Res 48(6):465-471
25. McGrath M, Michaud D, De Vivo I (2006) Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women. BMC Cancer 6, 6:239
26. Silig Y, Pinarbasi H, Günes S, Ayan S, Bagci H, Cetinkaya O (2006) Polymorphisms of CYP1A1, GSTM1, GSTT1, and prostate cancer risk in Turkish population. Cancer Invest 24(1):41-45. doi: 10.1080/ 07357900500449579
27. Aktas D, Hascicek M, Sozen S, Ozen H, Tuncbilek E (2004) CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population. Cancer Genet Cytogenet 154(1):81-85. doi: 10.1016/ j.cancergencyto.2004.01.023
28. Cao W, Cai L, Rao JY, Pantuck A, Lu ML, Dalbagni G et al (2005) Tobacco smoking, GSTP1 polymorphism, and bladder carcinoma. Cancer 104(11):2400-2408. doi: 10.1002/cncr.21446
29. Ateş NA, Unal M, Tamer L, Derici E, Karakaş S, Ercan B et al (2005) Glutathione S-transferase gene polymorphisms in presbycusis. Otol Neurotol 26(3):392-397. doi: 10.1097/01.mao.0000169774.23668.f1
30. Unal M, Tamer L, Ateş NA, Akbaş Y, Pata YS, Vayisoǧlu Y et al (2004) Glutathione S-transferase M1, T1, and P1 gene polymorphism in laryngeal squamous cell carcinoma. Am J Otolaryngol 25(5):317-322. doi: 10.1016/j.amjoto.2004.04.003
31. Tamer L, Ateş NA, Ateş C, Ercan B, Elipek T, Yildirim H et al (2005) Glutathione S-transferase M1, T1 and P1 genetic polymorphisms, cigarette smoking and gastric cancer risk. Cell Biochem Funct 23(4):267-272. doi: 10.1002/cbf.1148